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Abstract
Forward genetics screens with N-ethyl-N-nitrosourea (ENU) provide a powerful way to illuminate gene function and
generate mouse models of human disease; however, the identification of causative mutations remains a limiting step.
Current strategies depend on conventional mapping, so the propagation of affected mice requires non-lethal screens;
accurate tracking of phenotypes through pedigrees is complex and uncertain; out-crossing can introduce unexpected
modifiers; and Sanger sequencing of candidate genes is inefficient. Here we show how these problems can be efficiently
overcome using whole-genome sequencing (WGS) to detect the ENU mutations and then identify regions that are identical
by descent (IBD) in multiple affected mice. In this strategy, we use a modification of the Lander-Green algorithm to isolate
causative recessive and dominant mutations, even at low coverage, on a pure strain background. Analysis of the IBD regions
also allows us to calculate the ENU mutation rate (1.54 mutations per Mb) and to model future strategies for genetic screens
in mice. The introduction of this approach will accelerate the discovery of causal variants, permit broader and more
informative lethal screens to be used, reduce animal costs, and herald a new era for ENU mutagenesis.
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Introduction
Forward genetic screens in mice carrying mutations introduced
by the alkylating agent ENU can provide important and entirely
novel insights into gene function [1,2,3,4]. This approach does
not require any prior assumption about mechanism, and by
inducing random point mutations ENU generates viable pheno-
types that mimic human disease. In the classic approach mice
treated with ENU are bred to generate pedigrees segregating
thousands of mutations, which are screened for phenotypes of
interest. However determining which of the many induced
mutations underlies the phenotype is a significant bottleneck in
the process, requiring additional generations of breeding and
outcrossing to another inbred laboratory strain in order to
generate a linkage map, followed by sequencing of candidate
genes or regions. This process is time consuming and costly. For
example conventional fine mapping to obtain a linkage region of
around 3 Mb (20–30 genes) requires at least 2 generations of
additional breeding and genotyping 100–200 markers in 30–60
F2 mice. The need to propagate the mice tends to require non-
lethal screens, which limits the range of assays and the scope to
detect phenotypes. Furthermore, outcrossing can introduce
unseen confounding variants affecting the trait, and tracking
the phenotype through additional generations is complicated and
can be unreliable [5].
Although whole genome and exome sequencing offer the
prospect of accelerating discovery, current strategies remain
dependent on conventional mapping [6,7,8,9]. In this study we
address the ENU bottleneck by showing how it is possible to use
WGS and identity by descent to isolate a causative mutation
rapidly and efficiently on a pure, single strain background, without
the need for outcrossing or additional breeding. The strategy will
allow the use of lethal and more informative screens. It will
accelerate the discovery of new variants, permit a greater focus on
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novel mutations, and make forward genetics more accessible by
reducing costs and broadening the screens.
Results
A Novel Strategy to Identify ENU Mutations
In a typical strategy for generating and screening ENU mutant
mice, C57BL/6J (B6) ENU-treated founders are bred with B6
females to generate G1 founders, establishing pedigrees in which
pairs of G2 mice produce G3 mice segregating recessive and
dominant mutations (Figure 1A). To assess the utility of WGS in
the analysis of such mice, we chose a pedigree identified as
ENU16CH17a where the recessive phenotype was peripheral B cell
lymphopenia (Figure 1B and Figure S1), and performed WGS on
three affected G3 mice from a single G2 pair to high coverage
(average 246 per individual).
The causative variant in ENU16CH17a will belong to a
haplotype that is shared by all the sequenced mice and inherited
from an ENU-treated ancestor. By constructing chromosomal
maps of the homozygous variants in all three animals we could
demonstrate clustering of mutations within haplotype blocks
inherited from ENU-treated founders (Figure 1C and Figure 1D).
This suggested that the identification of IBD regions in multiple
mice would be an elegant and efficient approach for mapping and
identifying causative mutations. We developed a method based on
the Lander-Green algorithm which uses genetic markers, knowl-
edge of the pedigree and recombination rates, to infer the flow of
alleles through the genealogy [10]. We modified the algorithm to
exploit the partial knowledge of the G1 founder genotypes. Our
implementation uses probabilistic variant calls to identify haplo-
types from the four founder mice (ENU1, ENU2, WT1 and WT2)
across the genome of each G3 individual (Figure 2A and Materials
and Methods). The rate of ENU induced mutation is low and must
be distinguished from both WGS artifacts and background
variation from the reference, so we developed a series of filters
to exclude non-ENU variants (Materials and Methods and Figure
S2).
The haplotypes assigned by our algorithm identify the IBD
regions (Figure 2B). IBD homozygous regions comprise 95.3 Mb
(3.6% of the genome), containing 137 variants, including only two
mutations in coding regions, both on chromosome 4 (Figure 1D).
One mutation at position 3,710,143 was an A to G mutation
inducing a missense change in the Src-kinase encoding gene Lyn
(Figure 1E). The mutation corresponds to a threonine to an alanine
substitution at amino acid residue 410 in exon 12 within the highly
conserved Src activation loop in the protein kinase domain
(Figure 1F). The phenotype seen in ENU16CH17a has been
described in mice carrying a threonine to lysine substitution at the
same codon in Lyn [11], indicating that the LynT410A mutation is
causative. The other mutation, at position 66,590,107, encoded a
missense mutation in a single transcript of Toll-like receptor 4
reported by Ensembl (Tlr4-004 ENSMUST00000107365), but
absent from the RefSeq dataset. Tlr4 deficient mice do not have
obvious defects in B cell development [12].
Dominant Mutations
The ENU16CH17a pedigree carries a recessive functional
mutation; however, to demonstrate the wider application of our
method for dominant traits, we examined shared IBD heterozy-
gous ENU mutations in the same G3 mice. The 3 ENU16CH17a
mice share one or more haplotypes from a common ENU founder
across regions comprising 40.8% of the genome (1083.8 Mb)
(Figure 2B), containing 26 heterozygous candidate mutations
shared by all 3 mice, comprising 25 missense and one splicing
mutation; there were no nonsense mutations. PolyPhen-2 [13]
predicted 9 as benign, leaving 17 heterozygous shared mutations
with possibly deleterious effects. Sanger sequencing confirmed the
presence of all 28 homozygous and heterozygous IBD variants
(Table S1 and Table S2).
The Frequency and Characteristics of ENU Mutations
The frequency of ENU mutations is dose related [14,15] and
may differ according to the mouse strain [16]. However, previous
estimates of the ENU mutation frequency, which have ranged
from 0.5 Mb{1 to 10 Mb{1, have been confounded by small
datasets and locus specific bias [17,18,19,20,21,22,23].
By observing the frequency of variants in the homozygous ENU
regions and subtracting the background rate observed in
homozygous WT regions, we have calculated the ENU mutation
rate in the ENU16CH17a pedigree to be 1.54 mutations Mb{1.
We excluded errors due to assignment of homozygous regions or
inadequate coverage by modeling the effect of expansion or
contraction of regions and of reduction in coverage (Figure 3A and
3B). The estimate of mutation frequency was also insensitive to
changes in the assumed mutation frequency used in the algorithm
to predict IBD regions - with assumed mutation frequencies in the
range 0.25 to 3.0 mutations Mb{1, the estimated ENU frequency
remained between 1.52 and 1.58 mutations Mb{1 (Figure S3A).
Within the homozygous ENU regions, we could confirm the
well-described transition:transversion ratio and A-T base prefer-
ence of ENU induced mutations [24,25]. We found a 1.50:1
transition: transversion ratio in ENU mutations compared to a
2.17:1 ratio in naturally occurring mouse SNPs (Figure 3C). We
confirmed the distinctive base preference signature of ENU
mutations, which is mainly due to error-prone repair of O2 and
O4 ethylthymidine leading to AT to TA transversions (28.5% of
our mutations), and AT to GC transitions (45.0% of our
mutations), respectively [26,27] (Figure 3D). We found 78.7% of
all homozygous mutations were at A:T sites, compared to the 58%
AT content of the mouse genome [28] and different to non-ENU
Author Summary
Damaging mutations in single genes are an important
source of information about the causes of disease,
including more complex genetic disease; but these single
gene disorders are typically rare in humans. An important
strategy for identifying new disease mechanisms is to
introduce multiple random mutations in mice and test the
mice for biological differences; these mice act as models of
human disease. However, discovering the disease-causing
mutation is time-consuming and complex, requiring
further generations of breeding. In this study we demon-
strate a method that overcomes these problems by
sequencing the entire genomes of multiple mice that
have inherited a disease-causing mutation from a common
ancestor. We use an algorithm that uses knowledge of all
the mutations carried by the sequenced mice to identify
the regions of the genome and mutations that are
common to all the mice. Using this method we can rapidly
link biological traits to genetic mutations. In contrast to
current approaches, our strategy does not require large
amounts of breeding, and it permits more accurate
measurement of a wider range of traits; consequently its
introduction will significantly reduce the number of mice
required in the future, increase the number of traits that
can be detected, and accelerate the discovery of new
pathways and gene functions relevant to human diseases.
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Figure 1. Whole-Genome Sequencing Identifies the IBD Homozygous Region and Causative ENU Mutation. (A) The structure of an ENU
pedigree: two ENU treated males paired with WT B6 females generate founder G1 mice for the ENU16CH17a pedigree, and G3 mice exhibiting the
phenotype are selected for WGS. Thus mice within the pedigree carry 4 possible haplotypes, ENU1, ENU2, WT1 and WT2. A yellow star illustrates the
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variants seen in homozygous WT regions, of which 39.5% were at
AT sites (Figure 3E).
Identification of IBD Regions and Mutations at Low
Coverage
For a high throughput ENU program, an analysis based on IBD
would ideally identify SNPs and IBD regions accurately even at
low coverage per individual. Therefore to model this we simulated
a lower coverage dataset by randomly selecting subsets of
ENU16CH17a reads and checked the consistency of variant calls
at different simulated levels of coverage compared to 246 per
mouse. The assignment of IBD regions remained highly consistent
with the complete dataset down to very low coverage levels
(Figure 4A and Figure S4). At 56 coverage per mouse, 93% of
homozygous and 91% of heterozygous IBD regions seen at 246
were assigned, and 83% of homozygous and 77% of heterozygous
variants in IBD regions overlapped with those found in IBD
regions at full coverage (Figure 4B). Within the validated set of
non-synonymous coding and splice site mutations, we identified all
the homozygous IBD variants (2/2), and 69% of heterozygous
IBD variants (18/26) at 56 (Figure 4B).
We compared our IBD approach to a simple method of
selecting all variants observed in all 3 affected mice. At lower
coverage levels the simple approach identified very large numbers
of homozygous shared variants compared to the IBD method; at
56 coverage there were 586 shared variants compared to 158 by
IBD (Figure 4C). This error is likely to be due to the miscalling of
heterozygous variants as homozygous, coupled with accumulation
of further heterozygous variants, since the overall number of
heterozygous shared variants at each simulated depth is greater
than that observed using IBD (Figure 4D). By only considering
variants in IBD genomic intervals, we distinguished homozygous
from heterozygous variation more accurately and reduced the
number of spurious shared variants, making isolation of causative
mutations feasible at low coverage.
To confirm the utility of our method at low coverage
experimentally, we Sanger sequenced shared variants from 3
affected mice in a second ENU pedigree, which had been
sequenced by WGS at 46 per mouse. We again identified the
causative recessive mutation, and found true-positive rates of
85.7% (24/28) for homozygous variants and 86% (48/56) for
heterozygous variants. Within the subset of coding variants, we
identified 100% (4/4) of the homozygous variants, including the
causative variant, and 96% (24/25) of the heterozygous variants
(Table S4). As expected, Sanger sequencing of variants from non-
IBD regions revealed lower true-positive rates, 57% (49/86) of
called variants were confirmed by Sanger sequencing, comprising
59% (10/17) of coding variants and 57% (39/69) of non-coding
variants (Table S5), demonstrating once again the greater
accuracy of variant calling in IBD regions compared to non-IBD
regions at 46 coverage per mouse.
Modeling the Efficient Generation of ENU Libraries
To explore how our computationally efficient and rapid route
from phenotypes to candidate genes could be applied to a large-
segregation of a causative variant. (B) Mice homozygous for the mutation exhibit B cell lymphopenia (here gating on blood lymphocytes). (C) Plots of
homozygous filtered variants show the haplotype blocks across the chromosomes of each sequenced mouse. (D) Shared homozygous variants seen
in all 3 sequenced mice cluster in an IBD region on Chromosome 4, containing exonic mutations in two genes, Lyn and Tlr4. (E) Confirmation of the
Lyn A to G transition by Sanger sequencing. (F) The mutation lies in exon 12 within the catalytic domain.
doi:10.1371/journal.pgen.1003219.g001
Figure 2. Identification of IBD Regions using a Modified Lander-Green Algorithm. (A) Graphical representation of the output of the
algorithm, showing the genotypes for the 3 mice, based on combinations of the 4 haplotypes ENU1, ENU2, WT1 and WT2 inherited from the founder
mice. WT1 and WT2 are genetically indistinguishable. Each mouse is represented by a vertical third of the plot for each chromosome, and color blocks
represent unphased haplotype combinations for each mouse as indicated in the figure. ENU/ENU indicates homozygous ENU regions and ENU/WT
indicates heterozygous regions for ENU 1 or ENU 2. (B) Graphical representation of the chromosomal IBD regions, showing shared heterozygous
(blue) and homozygous (red) IBD regions. Regions are only IBD if all mice share alleles from a particular ENU founder, ENU1 or ENU2. Non
homozygous IBD regions in which all mice carry at least one matching ENU allele are considered IBD heterozygous.
doi:10.1371/journal.pgen.1003219.g002
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scale ENU program, we proceeded to model the inheritance of
mutations within a typical ENU pedigree.
First we asked how frequently a hypothetical fully penetrant
ENU mutation causing a screened phenotype would be observed
among the G3 mice in the proposed breeding strategy. We
assumed that a G1 pair could give rise to 4 stable G2 pairs, each
generating 3 litters with a conservative estimate of 4 live mice per
litter. A single pedigree would then generate 48 G3s for screening
(Figure 1A). Using a probabilistic model incorporating all the
possible inheritance patterns (Materials and Methods), we
calculated that 51% of ENU mutations present in the founder
mice occur 3 times or more as homozygous within the set of G3
mice, and 62% occur twice or more. 99.6% of mutations would be
present at least once as a single allele in the 48 G3 mice, 98% at
least 6 times and 95% at least 9 times (Figure 5A).
Next, we asked whether, under the proposed strategy, the
number of non-causative candidate mutations would be sufficient-
ly small to efficiently exclude these mutations. The number of
candidate mutations IBD in affected G3 mice from a single
pedigree can be estimated as a function of the number of affected
Figure 3. Characterization of the ENU Mutations. (A) The effect of expanding or contracting the homozygous ENU regions on the estimate of
the ENU mutation frequency. (B) The effect of simulated depth of coverage on the estimated ENU mutation frequency. (C) Transition transversion
ratio in homozygous ENU variants compared to a large dataset of non-mutagen induced laboratory mouse variation from the Centre for Genome
Dynamics Mouse SNP Database. (D) The distribution of ENU mutations, showing reference base pairs and substitutions (ref-sub). (E) The proportion of
homozygous mutations that occur at AT sites in homozygous ENU and homozygous WT regions. In each graph, columns or points show mean values
across the 3 sequenced ENU16CH17a mice.
doi:10.1371/journal.pgen.1003219.g003
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G3s sequenced, the empirical ENU mutation frequency of 1.54
mutations Mb{1 (Figure 3B), the relatedness of the mice and the
proportion of mutations that affect protein sense. We found on
average 1.4% (9.3/647.3) homozygous mutations in each G3
mouse lie in exons or splice sites; 73% of this subset caused
missense or splice site mutations; we identified no homozygous
stop mutations in ENU16CH17a. Thus we derive that 1.05% of
mutations affect protein sense. Using these parameters we
calculate that sequencing 3 or 6 mice will reduce the number of
candidates to 1 homozygote or 2–3 heterozygote mutations,
respectively (Figure 5B and Materials and Methods). This model is
consistent with the empirical data from the ENU16CH17a
pedigree.
Discussion
The importance of this study is in showing how low coverage
WGS of multiple mice with a phenotype can identify causative
ENU mutations without the need for out-crossing, or knowledge of
dominant or recessive inheritance. This strategy simultaneously
generates linkage maps and identifies the shared mutations with a
high degree of confidence. The advantage of our linkage-based
approach is that ENU-induced mutations from multiple affected
mice can be used to track the IBD regions and then isolate the
causative mutation.
Linkage analysis using exome sequencing has been effectively
harnessed for the study of human pedigrees. Variations on the
Figure 4. The Effect of Reduced Coverage on the Assignment of Regions and Variants by IBD. (A) The proportion of ENU homozygous
and heterozygous IBD regions from the full 246coverage dataset identified at simulated lower depths of coverage per mouse. (B) The proportion of
homozygous and heterozygous IBD variants from the 246 coverage dataset identified at simulated lower depths of coverage per mouse. The
validated variants are the coding or splice variants confirmed by Sanger sequencing (Table S1). (C) The number of IBD homozygous SNPs at different
simulated coverage depths compared to the number of shared homozygous SNPs across all 3 mice. (D) The number of IBD heterozygous SNPs at
different simulated coverage depths compared to the number of shared heterozygous SNPs across all 3 mice.
doi:10.1371/journal.pgen.1003219.g004
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Lander-Green method, developed for array data, incorporate
knowledge of the population allele frequencies of HapMap SNPs
[29,30,31]. Alternative approaches use other hidden Markov
models (HMM) to identify regions that are IBD and common to
autosomal recessive phenotypes [32,33]. Reducing the search space
from the whole genome to the exome significantly reduces the
number of informative variants [34], however this is typically several
orders of magnitude larger than the number of ENU-induced
exonic variants, e.g. 6000 to 8000 exonic HapMap variants per
individual [29,30] compared to 74 exonic variants in our ENU
pedigree. The low frequency of ENU coding variants does not
permit fine scale linkage analysis based only on exonic variants.
Exome sequencing also precludes the detection of regulatory
mutations [35], and the inefficiencies of capture have resulted in a
failure to find the causative mutant in one in five ENU pedigrees,
even for recessive traits [8,36]. The ability to detect IBD regions
using low coverage and the falling costs of next generation
sequencing make our WGS method increasingly cost effective.
Knowledge of the ENU mutation frequency allows us to model
an efficient sequencing strategy. Our data show that sequencing 3
affected G3 mice with a recessive trait or 6 mice with a dominant
trait would yield on average 1 or 2 candidate IBD mutations. The
Lander-Green algorithm on which our IBD analysis is based,
scales exponentially with the number of individuals in the
pedigree, but remains computationally feasible with a pedigree
of n individuals and f founders where 2n{fƒ25 [31,37]. The
algorithm would accommodate further refinement to take into
account the known characteristics of ENU mutations (Figure 3D).
By generating haplotype data for many ENU pedigrees, our
approach will also eventually lead to a fine scale map of active
recombination sites in the mouse, which, unlike existing maps
based on recombinations that arose historically between outbred
strains of mice [38] or more recently between intercrossed inbred
strains [39], is unbiased by selection or strain differences. Such a
map could then be used to optimize the performance of our
Lander-Green based algorithm.
We believe that the adoption of our approach by large-scale
ENU programs will lead to a substantial increase in the
productivity of the programs, advancing our understanding of
gene-function and the mechanisms of genetic disease. Our
approach will reduce the burden in animal costs and allow post-
mortem screens, with increased sophistication and accuracy in a
broader range of tissues. With the rapidly falling costs of WGS we
can envisage a future in which all G3 ENU mice are sequenced to
a depth sufficient to identify and segregate all their mutations,
creating a rich dataset of allelic variation and corresponding
phenotypic information, including linkage data for non-coding
mutations with measurable effects. This could be achieved
accurately with 4–56 sequencing due to the increased power to
impute genotypes. This database could be mined for associations
across pedigrees, including the detection of subtle phenotypes.
Materials and Methods
ENU
ENU16CH17aENU treated B6 mice were generated and
screened at the Australian Phenomics Facility, The Australian
National University, Canberra [40]. Male founder mice for each
pedigree, 8–15 weeks old, were treated three times 1 week apart
with 90–100 mg/kg N-ethyl-N-nitrosourea (Sigma) prepared in
10% ethanol, citrate buffer (pH 5.0). After 8 weeks, the treated
mice were mated with B6 females. Individual G1 progeny were
intercrossed to generated G2 pairs. Phenotypic screening of G3
mice included flow cytometry of peripheral lymphoid cells
(Figure 1A). We obtained tail DNA from 3 affected G3 siblings
from the ENU16CH17a pedigree.
Whole-Genome Sequencing, Mapping, and Variant
Calling
We performed DNA sequencing on an Illumina HiSeq 2000
machine, using two lanes per mouse. 100 bp paired-end reads
were generated. We mapped reads to the mouse reference genome
Figure 5. Modeling the Frequency of Mutants and the Power to Assign Causation by WGS. (A) The frequency distribution for all mutations
within a pedigree at the G3 level, based on a model pedigree of 48 G3 arising from 4 G2 pairs (Materials and Methods). In the specific case of
mutations causing fully penetrant phenotypes, the histograms show the distribution of affected mice with recessive (2 allele) and dominant (1 allele)
traits. (B) The number of IBD candidate mutations, defined as missense, stop or splice-variants, as a function of the number of sequenced affected G3
mice, based on our model.
doi:10.1371/journal.pgen.1003219.g005
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MGSCv37 using Stampy [41] with BWA settings. 94.5% of
genome was covered at least once, mean coverage across the
genome 24 fold per mouse. An in-house variant caller Platypus
was used, version 0.1.8 (www.well.ox.ac.uk/platypus A.J.R,
Mathieson I, G.L, McVean G, (2012)). We annotated the variants
using Annovar [42] with Ensembl (release 64) gene annotation.
Functional predictions were made using Polyphen-2 using
probabilistic classifications based on a model trained with the
HumVar dataset, tailored for detection of Mendelian disease
caused by mutations with large effects. Although the training
dataset consists of human disease causing mutations, the modeling
is based on sequence and structural features applicable across
species [13] and higher Polyphen-2 scoring has been shown to
correlate with damaging murine ENU mutations [36]. The
LynT410A mutation in ENU16CH17a was confirmed independent-
ly using exome sequencing [36].
Variant Filters and Union File
We developed a pipeline to filter the variant calls. As a first step
we eliminated variants previously observed in two or more other
ENU pedigrees using a variant union file (Figure S2), since these
could be assumed to be due to systematic error, for example in
repetitive regions with mismapping, or true non-ENU variation
from the reference mouse sequence. To create this union file of
shared, and thus non-ENU, variation, Platypus was used to call
variants from mice from 9 different ENU pedigrees simultaneous-
ly. Thus at each variant locus a genotype and genotype likelihood
was assigned for all mice. The nine pedigrees included 6 from the
Australian Phenomics Facility at the Australian National Univer-
sity, 2 from the MRC Harwell Centre for Mouse Genetics and one
from the Beutler Group at The Scripps Research Institute. The
Harwell pedigrees and one of the ANU mice were on a mixed
strain background. All other mice were on a straight B6
background (as was ENU16CH17a). We identified 7,624,313
unfiltered calls amongst these 9 pedigrees from 3 centers (Figure
S2A). In order to exclude ENU variation we removed variants
observed in only one pedigree. 83.6% (6,371,574/7,624,313) of
raw variant calls were shared by more than one pedigree (Figure
S2B). Within this dataset of shared variants there were 6,371,548
unique genomic positions, 81.7% were SNPs (5,203,298) and
18.3% (1,168,250) indels). transition:transversion ratio among
SNPs was 1.9% (3,394,771 transitions, 1,805,983 transversions,
2,544 have more than 2 alleles). To examine the proportion of this
shared variation attributable to B6 reference strain mice, we
excluded shared variants exclusively observed in mixed strain
mice. The resultant shared variants are observed in at least 2
pedigrees, including at least one fully B6 pedigree. Since all
pedigrees included from MRC Harwell are mixed strain, the
MRC Harwell variants fully overlap the other laboratories (Figure
S2C). The large majority (91.8%) of non-ENU variation in B6
mice is not laboratory specific, suggesting isolated genetic drift
within individual colonies accounts for little of the observed
variation. 24.1% of the shared dataset were present in dbSNP.
After filtering non-ENU variation from the ENU16CH17a calls,
we removed any additional known variants from dbSNP (version
128) and filtered out remaining calls that were clustered closely
together with a threshold of less than 1,000 bp. The variants were
then filtered for Phred based quality score assigned by the variant
caller v20, removal of calls that failed Platypus allele bias or
strand bias filters, removal of variants with a high local frequency
of bad reads, filters for homopolymers and repetitive sequence,
including di-nucleotide repeats of 20 bp or more. Indels were
removed as ENU overwhelmingly causes point mutations. Finally
loci with coverage in the upper or lower 1% of the coverage
distribution were excluded. All coverage distributions were
measured with BEDTools [43].
Lander-Green Based Algorithm
The Lander-Green algorithm [10] uses a combination of
genotype information from informative markers (here, the SNP
genotypes called from the next-generation sequencing data), and
knowledge of local recombination rates to determine the ancestral
haplotypes in specific genomic intervals, and the locations at which
recombinations and therefore transitions between inheritance state
vectors occur.
The pedigree used in this experiment (Figure 1A) can be
considered to originate with the G1 pair of common ancestors who
each carry a combination of the haplotypes inherited from the G0
mice, these being ENU1, ENU2, WT1 and WT2. Thus for the
purpose of the algorithm the pedigree consists of 5 non-originals –
that is 5 individual mice with parents in the pedigree.
The Lander-Green algorithm represents the ancestral haplo-
types of the 5 non-originals as a state vector with 10 binary co-
ordinates, representing the 5 individual mice, arising from 10
gametes. Within each inheritance vector a 0 coordinate indicates a
gamete carrying grand-paternal DNA at a locus, and 1 indicates
grand-maternal inheritance. These are arbitrarily phased. There
are 210 possible state vectors.
The standard HMM machinery is well documented [44]. A
HMM has two main components which are model-specific: these
are the state transition matrix, which specifies the probabilities of
transitions between any two model states, and the likelihood, which
is the probability of the observed data given a particular model state.
The Lander-Green algorithm uses a state transition matrix based on
the recombination rate, which encodes the probabilities of
transitions between any of the ancestral state vectors, based on
the number of recombinations required for the transition. In our
implementation we use a recombination map [39] to compute
average local recombination rates across the genome. We do not
store the whole transition matrix in memory, but compute matrix
elements on demand. This is straight-forward, as all matrix entries
can be expressed as powers of the recombination rate and one
minus the recombination rate. This vastly reduces the memory
requirements for the algorithm, which are now linear in the number
of state vectors rather than quadratic.
For each G3, a state vector determines which two ancestral
haplotypes that make up G1, make up the local genotype, e.g.
(ENU1, WT2). We compute a probability for the observed SNP
genotypes, given each ancestral state vector, in 100 kb windows
across each chromosome. This probability has two components: a
prior probability of observing a SNP in the given window, and
genotype likelihoods computed by the variant caller from the
sequence data. We assume fixed priors of observing a SNP in ENU
haplotypes (2Mb{1) and WT haplotypes (0:2Mb{1). The IBD
regions inferred by the algorithm were relatively insensitive to
changes in these priors (Figure S3B).
The likelihood for a particular state vector is the sum over all
possible combinations of the SNP genotypes (0/0, 1/0, 1/1) for
the 3 mice, of the product of the SNP priors and the relevant
genotype likelihoods for the 3 G3 mice. This incorporates the
dependent relationships between the mice. In the case of multiple
SNPs occurring in the same window, we assume that the SNPs are
independent, and the likelihood for all mice in the window is the
product of the likelihoods across all SNPs. Using the genotype
likelihoods from the caller allows us to accommodate errors in the
WGS data; a modification to the conventional Lander-Green
algorithm that has been used to infer IBD in array data. [45].
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Due to the paucity of polymorphic sites in the in-bred B6
mouse, there are many 100 kb windows which contain no SNPs. If
no SNPs were called in a window, the most likely explanation is
that no SNPs were present. In a small fraction of cases, a real SNP
will be missed due to low coverage or variant-calling errors. To
deal with windows that contain no SNPs, we supply a set of
likelihoods weighted towards 0/0. Specifically we assume a 1/10
probability that a heterozygous SNP was missed, and a 1/100
probability that a homozygous SNP was missed.
Finally, we use the forward backward algorithm [44] to
compute the posterior probability of each state vector at each
window. We select the state vector with the highest posterior in
each window to construct the sequence of most probable
inheritance states across each chromosome. This information is
shown in Figure 2A.
The program was coded in Python (http://www.python.org) and
Cython (http://cython.org). The code is freely downloadable from
http://www.well.ox.ac.uk/lgenu. Graphical plots of genotypes were
generated using matplotlib (http://matplotlib.sourceforge.net).
Within our three generation pedigree, frequent recombinations,
particularly from state A to state B and back to state A within a
small genomic interval are likely to be artifactual. Therefore we
performed a smoothing step on the output inheritance states, such
that recombinations from state A to state B and back to state A
within 1 Mb, within an allele, are corrected to state A.
In reporting the results we define IBD heterozygous throughout
to refer to regions or variant sets in which all sequenced individuals
share at least one allele from the same ENU founder but are not
IBD homozygous.
Frequency and Characteristics of ENU Mutations
Our dataset includes on average 647 mutations per mouse in
homozygous regions spanning over 1,000 Mb across 3 mice (mean
405 Mb, 15.3% of the genome, per mouse). Sanger sequencing of
the candidate mutations confirms the reliability of our filtered call
set (Table S1). By observing the frequency of these mutations and
subtracting the low background frequency from homozygous WT
regions, we estimated the ENU mutation frequency, and used the
homozygous ENU region variants to examine the base preference of
ENU mutations. Comparison of the transition transversion ratio
was made with all the variants in the Centre for Genome Dynamics
Mouse SNP Database (http://cgd.jax.org/cgdsnpdb) on 8.5.12.
This database includes over 66 million SNPs from 136 inbred
laboratory mouse strains predominantly imputed from the mouse
diversity array [46], and is representative of the characteristics of
naturally occurring (non-ENU) SNPs in an inbred mouse.
Simulating Lower Coverage Depths in Our Empirical
Dataset
We generated random subsets of reads from the ENU16CH17a
bam file using a script that utilizes pysam, a SAMtools [47]
interface for Python. For details see http://code.google.com/p/
pysam/. We called and filtered variants on the down-sampled bam
files using the same pipeline described above. Comparisons of IBD
regions and variant calls between the lower coverage datasets and
the full (246) coverage data were made using BEDTools [43] to
measure intersections. The intersections of IBD regions were
analyzed by a per base pair comparison.
Comparison with Non–IBD Approach to Detect Shared
Variation
To examine whether an IBD method performs better than a
simple per SNP approach to detect shared variation in the 3 mice
attributable to ENU we generated a comparison set of shared
variants at each simulated coverage depth by selecting variants
that were observed in all 3 mice. In exactly the same way as with
the IBD variants we included SNPs in which there was at least one
homozygous or heterozygous mouse and the remaining 0, 1 or 2
mice had no genotype information (denoted :=: in the vcf file) or a
reference (0=0) genotype call with at least one variant call and less
than 5 supporting reference reads.
Calculating the Proportion of Mutations Affecting Protein
Sense
To examine the distribution between missense and splice
mutations we looked at the larger dataset of heterozygous
mutations. Across our three mice, 86% (21.7/25) of potentially
damaging mutations were missense mutations, 6% (1.3/25) were
nonsense mutations and 8% (2/25) were in splice sites. A large
database (http://mutagenetix.utsouthwestern.edu/ on 8.5.12) of
over 5,000 incidental ENU mutations with no observed deleterious
effects, identified in the course of next generation sequencing
(Applied Biosystems SOLiD), reports 85.9% missense, 4.4%
nonsense and 9.7% splicing mutations, and agrees broadly with
our findings.
Modeling Expected Numbers of ENU Mutations in G3
Mice
To model the segregation of mutations within a pedigree, we
calculated the probability of a mutation being inherited by a G3
under the three possible situations where the G2 parents carry 0, 1
or 2 copies of the mutation (in 25%, 50% and 25% cases
respectively; individual G2 mice are not homozygous for any ENU
mutation). We denote the chance of inheriting the mutation at G3
under each of these situations with a given zygosity (homozygous
or heterozygous) at G3 as P0, P1, and P2. Clearly some of these
probabilities will be 0.
Conditional on the number of mutations carried by the G2
parents, the number n of G3 offspring inheriting the mutation with
the required zygosity can be modeled using a binomial distribu-
tion. For a given G2 parent pair, we denote this distribution by
f (n). Assuming that each G2 pair produces 3 litters of 4 live mice,
this distribution is given by
f (n)~0:25
12
n
 !
Pn0(1{P0)
12{nz
0:5
12
n
 !
Pn1(1{P1)
12{nz0:25
12
n
 !
Pn2(1{P2)
12{n
ð1Þ
Here
12
n
 
or 12 choose n denotes the binomial co-efficient
indexed by 12 and n. To estimate the probability of M G3
carrying the mutation across the 48 G3 from 4 G2 pairs, we can
convolute across all combinations of mice that together transmit
precisely M mutations with the required zygosity from G2 pairs,
such that
Prob(m~M)~
X
izjzkzl~M
f (i)f (j)f (k)f (l) ð2Þ
We considered two situations: one of a recessive mutation, in
which a G3 has two alleles from parents that are heterozygous for
the mutant; and the situation of a dominant mutation, where we
considered that homozygotes may also have the phenotype and
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may be indistinguishable from heterozygotes. In this way it is
possible to calculate the probability of any recessive or dominant
mutation carried by a founder occurring M times in the G3 mice.
The results are presented in Figure 5A.
Modeling Numbers of Shared IBD SNPs in Multiple
Sequenced Mice
We modeled the proportion of the genome expected to be IBD
in q sequenced mice without accounting for linkage to the
causative mutation. We calculated the probability of M G3
carrying a shared ancestral haplotype at any locus as described
above in equation 2 Prob(m~M), for each M between q and 48
(the modeled number of G3 mice), and calculated a probability of
picking q mice sharing such a locus by chance from a pool of M
mice sharing the locus and 48{M individuals not carrying the
locus. Since each mouse can only be picked once this corresponds
to a hypergeometric distribution. We then summed over the
product of this and the Prob(m~M) for each M between q and
48 to get the overall probability, R, of any unlinked locus being
observed in all the affected sequenced mice.
R~
P48
M~q
Prob(m~M)
M
q
 
48{M
q{q
 
48
q
 
~
P48
M~q
Prob(m~M)
M
q
 
48
q
 
ð3Þ
R is the proportion of the genome expected to be IBD for a
specified number q of sequenced mice. We used our knowledge of
the ENU mutation rate (1.54 mutations Mb{1), and the fraction
of variation affecting protein sense (1.05% missense, nonsense or
splicing), to estimate the number of homozygous or heterozygous
candidate mutations shared by q affected sequenced mice.
Numberof shared candidates~R  1:54  1:05
We add one mutation to model the causative mutation which is
always present. In phenotypically affected mice a region from the
ENU founder persists around the causative mutation due to
linkage, and this adds another fraction ( 1
c
)( 1
m
)k of the genome,
where c is the fractional size of the chromosome, m is the
number of meioses per G3 mouse, and k is the number of G3
mice. This approximates to a further 0.7 mutations or 7  10{3
candidate coding mutations. Since this is negligible we simply
approximate to 1 additional mutation. The results are presented
in Figure 5B.
Sanger Sequencing
We amplified the 28 candidate mutations with two rounds of
PCR from genomic DNA using internal and external fully nested
primers (Table S3) and then amplified with Big Dye (Applied
Biosystems Ltd) before sequencing on an Applied Biosystems
3720xl machine. All nested sequencing reactions were run in
duplicate to check for PCR error. We carried out Sanger
sequencing to validate shared variants from the 3 mice sequenced
at low coverage from a second pedigree using primers shown in
Table S4 and Table S5.
Statistical Methods
Analysis of means was performed using the Graphpad Prism 5
package. All other analyses were written in custom scripts and
described in the Materials and Methods.
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Supporting Information
Figure S1 Splenic B Cell Populations in ENU16CH17a. (A)
B220 and CD93 within the CD45z CD19z B cell population. (B)
Immature B cells gated on CD45z CD19z CD93z, indicating
the T1 (IgMhi CD23{), T2 (IgMhi CD23z) and T3 (IgMlo
CD23{) populations. (C) Mature B Cells gated on CD45z
CD19z CD93{. Follicular (IgMlo CD21hi ) and marginal zones
(IgMhi CD21hi ). (D) Follicular B cells gated on CD45z CD19z
CD93{ IgMlo CD21hi showing IgM vs IgD, expression of IgM
falls and IgD increases with maturity of follicular B cells.
(EPS)
Figure S2 Variant Union File—Distribution of Variations by
Laboratory. (A) All variants called over 9 ENU pedigrees from 3
centers. (B) All variants observed in more than one pedigree. (C)
All variants seen in more than one pedigree including at least one
pedigree on a straight B6 background. Each shape in the Euler
diagrams represents the pedigrees from a single centre.
(EPS)
Figure S3 Effect of Modeled ENUMutation Frequency Input to
Lander-Green Algorithm on Output Measures. (A) Effect of input
ENU mutation frequency on the estimated ENU mutation
frequency from the IBD regions. We ran the Lander-Green
algorithm using a range of assumed ENU mutation frequencies as
inputs, and estimated the mutation frequency from the data
generated as described in Materials and Methods. (B) Effect of
input ENU mutation frequency on the assigned IBD homozygous
and heterozygous regions. All regions are compared to those
generated using an input rate of 2:0Mb{1. Loss of regions is %
loss compared to the regions at 2:0Mb{1. Gain is % of regions
assigned using each input that were inconsistent with those seen at
2:0Mb{1 input.
(EPS)
Figure S4 IBD Regions Assigned at each Simulated Coverage
Level. Plots of IBD regions from the assigned inheritance states for
each mouse, shown at different simulated coverage levels.
Coverage level is the mean depth per mouse.
(TIF)
Table S1 Candidate Variants. The total shared homozygous or
heterozygous regions contained 2,951 mutations from the filtered
call set (2,191 were present in all 3 mice), including the 2 non-
synonymous homozygous mutations, and 30 heterozygote mis-
sense, nonsense or putative splice site mutations; 28 candidate
homozygous or heterozygous variants were present in all 3 mice.
(PDF)
Table S2 Variants in IBD Regions with Inconsistent Genotypes.
4 protein sense changing variants within the IBD regions were
rejected as causative because they were absent in one or more
affected animal, despite good individual depth of coverage
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(thresholdw5 good quality reads at the locus for the inconsistently
genotyped animal).
(PDF)
Table S3 Forward and Reverse Primers used to Validate
Candidate ENU16CH17a Variants.
(PDF)
Table S4 IBD Variants in the Second Pedigree Sequenced at
Low Coverage (46 per individual) used to examine the false
discovery rate at low coverage. The variants in this low coverage
pedigree were a randomly selected subset of the filtered shared
IBD variants and included both coding and non-coding mutations.
Sanger sequencing results: True Positive (TP), False Positive (FP)
Failed Sequencing (Unknown - assumed FP).
(PDF)
Table S5 Non-IBD Variants in the Second Pedigree Low
Coverage. Non-IBD variants selected randomly from the low
coverage pedigree (46 coverage per mouse), showing SNP
genotype from variant caller for each mouse. Sanger sequencing
results: True Positive (TP), False Positive (FP) Failed Sequencing
(Unknown - assumed FP).
(PDF)
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